MEDIA ADVISORY: KPMG thought leaders available for interviews at Web Summit Vancouver
KPMG subject matter specialists to share insights with organizations, investors and media at one of the world’s premier tech conferences VANCOUVER, BC, May... Read more.
eFuse Market worth $737.4 million by 2030 | MarketsandMarkets™
DELRAY BEACH, Fla., May 23, 2025 /PRNewswire/ — The global eFuse Market is anticipated to grow from estimated USD 557.0 million in 2024 to USD 737.4 million... Read more.
China Matters’ Feature: Bridging Cultures at China-CEEC Expo: Central and Eastern European Voices in Ningbo
NINGBO, China, May 23, 2025 /PRNewswire/ — As the 2025 China-Central and Eastern European Countries Expo opened in Ningbo on May 22, cultural and business... Read more.
Phyn Acquired by Investment Group Led by Property Brothers’ Jonathan Scott to Accelerate Growth in Smart Water Solutions
LOS ANGELES, May 23, 2025 /PRNewswire/ — Phyn, the industry leader in intelligent water solutions, has been acquired by a powerhouse group of investors led... Read more.
Bybit Card Rolls Out New Lucky Draw for Guaranteed Wins Including a Tesla
DUBAI, UAE, May 23, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is excited to celebrate the high... Read more.
Six Abstracts of Kelun-Biotech’s Clinical Studies Published at the 2025 ASCO Annual Meeting
CHENGDU, China, May 23, 2025 /PRNewswire/ — The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting is scheduled to take place in Chicago, Illinois,... Read more.
Tuniu Announces Receipt of Minimum Bid Price Notice from Nasdaq
NANJING, China, May 23, 2025 /PRNewswire/ — Tuniu Corporation (Nasdaq: TOUR) (“Tuniu” or the “Company”), a leading online leisure... Read more.
vivo Expert Dr. Wang Ruixin Wins 3GPP Excellence Award for Outstanding Contribution to 5G OTA Standards
SHENZHEN, China, May 23, 2025 /PRNewswire/ — 3GPP (3rd Generation Partnership Project) formally announced that Dr. Wang Ruixin, a leading telecommunications... Read more.
Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting
Preliminary efficacy analysis from the elacestrant plus everolimus and ribociclib cohorts of the ELEVATE study, along with updated safety data from additional cohorts... Read more.
B2BROKER Launches First-Ever Turnkey Liquidity Provider Solution
DUBAI, UAE, May 23, 2025 /PRNewswire/ — B2BROKER, a leading global fintech solutions provider, has announced the launch of Liquidity Provider Turnkey, a comprehensive... Read more.